These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30412490)

  • 1. Aging-Related Calcium Dysregulation in Rat Entorhinal Neurons Homologous with the Human Entorhinal Neurons in which Alzheimer's Disease Neurofibrillary Tangles First Appear.
    Gant JC; Kadish I; Chen KC; Thibault O; Blalock EM; Porter NM; Landfield PW
    J Alzheimers Dis; 2018; 66(4):1371-1378. PubMed ID: 30412490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
    Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.
    García-Sierra F; Hauw JJ; Duyckaerts C; Wischik CM; Luna-Muñoz J; Mena R
    Acta Neuropathol; 2000 Jul; 100(1):29-35. PubMed ID: 10912917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
    Muramori F; Kobayashi K; Nakamura I
    Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression correlates of neurofibrillary tangles in Alzheimer's disease.
    Dunckley T; Beach TG; Ramsey KE; Grover A; Mastroeni D; Walker DG; LaFleur BJ; Coon KD; Brown KM; Caselli R; Kukull W; Higdon R; McKeel D; Morris JC; Hulette C; Schmechel D; Reiman EM; Rogers J; Stephan DA
    Neurobiol Aging; 2006 Oct; 27(10):1359-71. PubMed ID: 16242812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-beta, tau, and dementia.
    Takashima A
    J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology.
    Llorens F; Thüne K; Andrés-Benito P; Tahir W; Ansoleaga B; Hernández-Ortega K; Martí E; Zerr I; Ferrer I
    J Mol Neurosci; 2017 Oct; 63(2):206-215. PubMed ID: 28871468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
    Bonkale WL; Cowburn RF; Ohm TG; Bogdanovic N; Fastbom J
    Brain Res; 1999 Feb; 818(2):383-96. PubMed ID: 10082824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of caspase-6 in aging and mild cognitive impairment.
    Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
    Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer's Disease.
    Del Tredici K; Schön M; Feldengut S; Ghebremedhin E; Kaufman SK; Wiesner D; Roselli F; Mayer B; Amunts K; Braak H
    J Alzheimers Dis; 2024; 101(4):1333-1353. PubMed ID: 39302368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease.
    Benzing WC; Mufson EJ
    Exp Neurol; 1995 Apr; 132(2):162-71. PubMed ID: 7540552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
    Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
    Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
    García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
    J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereologic evidence for persistence of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer disease.
    Hof PR; Bussière T; Gold G; Kövari E; Giannakopoulos P; Bouras C; Perl DP; Morrison JH
    J Neuropathol Exp Neurol; 2003 Jan; 62(1):55-67. PubMed ID: 12528818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease.
    Fukutani Y; Kobayashi K; Nakamura I; Watanabe K; Isaki K; Cairns NJ
    Neurosci Lett; 1995 Nov; 200(1):57-60. PubMed ID: 8584267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.
    Leng K; Li E; Eser R; Piergies A; Sit R; Tan M; Neff N; Li SH; Rodriguez RD; Suemoto CK; Leite REP; Ehrenberg AJ; Pasqualucci CA; Seeley WW; Spina S; Heinsen H; Grinberg LT; Kampmann M
    Nat Neurosci; 2021 Feb; 24(2):276-287. PubMed ID: 33432193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.
    Llamas-Rodríguez J; Oltmer J; Greve DN; Williams E; Slepneva N; Wang R; Champion S; Lang-Orsini M; Fischl B; Frosch MP; van der Kouwe AJW; Augustinack JC
    J Alzheimers Dis; 2022; 87(3):1379-1399. PubMed ID: 35491780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease.
    Polydoro M; de Calignon A; Suárez-Calvet M; Sanchez L; Kay KR; Nicholls SB; Roe AD; Pitstick R; Carlson GA; Gómez-Isla T; Spires-Jones TL; Hyman BT
    J Neurosci; 2013 Aug; 33(33):13300-11. PubMed ID: 23946388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of stimulatory effect of guanosine triphosphate on [(35)S]GTPgammaS binding correlates with Alzheimer's disease neurofibrillary pathology in entorhinal cortex and CA1 hippocampal subfield.
    García-Jiménez A; Cowburn RF; Ohm TG; Lasn H; Winblad B; Bogdanovic N; Fastbom J
    J Neurosci Res; 2002 Feb; 67(3):388-98. PubMed ID: 11813244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.